Griesbach A - Search Results

1

Genetic separation of GvL and GvH reactivity in new recombinant-inbred tumor-resistant mouse strains.

Schirrmacher V, Griesbach A, Gehring M, Lehr B. Schirrmacher V, et al. Among authors: griesbach a. Int J Oncol. 1996 Jun;8(6):1035-43. doi: 10.3892/ijo.8.6.1035. Int J Oncol. 1996. PMID: 21544461

2

Tumor-immune memory T cells from the bone marrow exert GvL without GvH reactivity in advanced metastasized cancer.

Schirrmacher V, Beckhove P, Choi C, Griesbach A, Mahnke Y. Schirrmacher V, et al. Among authors: griesbach a. Int J Oncol. 2005 Oct;27(4):1141-9. Int J Oncol. 2005. PMID: 16142333

3

Characterization of a murine lymphoma cell line by 31P-NMR spectroscopy: in vivo monitoring of the local anti-tumor effects of systemic immune cell transfer.

Fichtner KP, Schirrmacher V, Griesbach A, Hull WE. Fichtner KP, et al. Among authors: griesbach a. Int J Cancer. 1996 May 16;66(4):484-95. doi: 10.1002/(SICI)1097-0215(19960516)66:4<484::AID-IJC12>3.0.CO;2-8. Int J Cancer. 1996. PMID: 8635864

4

Tumor stimulator cell modification by infection with Newcastle Disease Virus: analysis of effects and mechanism in MLTC-CML cultures.

Schirrmacher V, Jurianz K, Roth C, Griesbach A, Bonifer R, Zawatzky R. Schirrmacher V, et al. Among authors: griesbach a. Int J Oncol. 1999 Feb;14(2):205-15. doi: 10.3892/ijo.14.2.205. Int J Oncol. 1999. PMID: 9917494

5

Antitumor effects of Newcastle Disease Virus in vivo: local versus systemic effects.

Schirrmacher V, Griesbach A, Ahlert T. Schirrmacher V, et al. Among authors: griesbach a. Int J Oncol. 2001 May;18(5):945-52. doi: 10.3892/ijo.18.5.945. Int J Oncol. 2001. PMID: 11295039

6

Intra-pinna induction of specific antitumor immune T cell functions.

Schirrmacher V, Jurianz K, Griesbach A. Schirrmacher V, et al. Among authors: griesbach a. Int J Oncol. 1997 Aug;11(2):227-33. doi: 10.3892/ijo.11.2.227. Int J Oncol. 1997. PMID: 21528204

7

Effective immune rejection of advanced metastasized cancer.

Schirrmacher V, Beckhove P, Kruger A, Rocha M, Umansky V, Fichtner K, Hull W, Zangemeisterwittke U, Griesbach A, Jurianz K, Vonhoegen P. Schirrmacher V, et al. Among authors: griesbach a. Int J Oncol. 1995 Mar;6(3):505-21. doi: 10.3892/ijo.6.3.505. Int J Oncol. 1995. PMID: 21556565

8

Adoptive transfer of protective immunity against a high metastatic tumor-cell variant by small numbers of tumor-specific in-situ activated peritoneal effector T-cells.

Schirrmacher V, Griesbach A, Umansky V, Rocha M. Schirrmacher V, et al. Among authors: griesbach a. Int J Oncol. 1994 Aug;5(2):141-51. doi: 10.3892/ijo.5.2.141. Int J Oncol. 1994. PMID: 21559568

9

Persistence of dormant tumor cells in the bone marrow of tumor cell-vaccinated mice correlates with long-term immunological protection.

Khazaie K, Prifti S, Beckhove P, Griesbach A, Russell S, Collins M, Schirrmacher V. Khazaie K, et al. Among authors: griesbach a. Proc Natl Acad Sci U S A. 1994 Aug 2;91(16):7430-4. doi: 10.1073/pnas.91.16.7430. Proc Natl Acad Sci U S A. 1994. PMID: 8052600 Free PMC article.

10

In vivo 1H-NMR microimaging with respiratory triggering for monitoring adoptive immunotherapy of metastatic mouse lymphoma.

Fichtner KP, Schirrmacher V, Griesbach A, Hull WE. Fichtner KP, et al. Among authors: griesbach a. Magn Reson Med. 1997 Sep;38(3):440-55. doi: 10.1002/mrm.1910380313. Magn Reson Med. 1997. PMID: 9339446

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters